Do we need separate screening strategies for cytomegalovirus retinitis in different underlying immunosuppressed states ? A retrospective study from Western India
Conclusion: Duration of treatment for CMV retinitis in patients of ALL was longer as compared to the other etiologies, and in recurrences, it needed to be continued till the completion of maintenance therapy for ALL. It is prudent to advise regular ophthalmic screening of all immunocompromised patients, as they are at a high risk of developing CMV retinitis. Patients of ALL, especially while on maintenance therapy, should be monitored for possible development or reactivation of CMV retinitis.
Source: Indian Journal of Ophthalmology - Category: Opthalmology Authors: Bindiya Doshi Niha Z Khatib Sumita Phatak Rohit Modi Sarvesh Tiwari Anand Subramanyam Source Type: research
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Cytomegalovirus | Eyes | India Health | Kidney Transplant | Kidney Transplantation | Leukemia | Lymphoma | Opthalmology | Study | Transplant Surgery | Transplants | Urology & Nephrology